Warning letter
Klinge Chemicals Limited [ARCHIVED]: warning letter of Dec 21, 2010
FDA warning letter 140430 · Center for Drug Evaluation and Research
Key facts
| Reference number | 140430 |
|---|---|
| Company | Klinge Chemicals Limited [ARCHIVED] |
| Subject | CGMP for Deviations/Adulterated |
| Issue date | Dec 21, 2010 |
| Posted date | Dec 21, 2010 |
| Issuing office | Center for Drug Evaluation and Research |
| Product type | Drugs |
| Inspection city | East Kilbride |
| Inspection start date | Jun 1, 2010 |
| Letter on fda.gov | web.archive.org |
At a glance
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: